A medicinal chemist from Austria had an idea and clubs, including Dortmund, have taken note. But how is saliva used to ...
New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.
The CEO of a joint payer-provider organization discusses the challenges of competing with commercial insurers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results